Transmucosal drug delivery is a novel route of drug administration which includes buccal, nasal, vaginal, and urethral cavities as route of drug delivery. Technological advancements and growing focus on research and development to analyze new delivery systems for medication in human have cemented the method for transmucosal drug delivery market in the recent times. Transmucosal drug delivery system offers various advantages over other routes of drug administration, making it a highly lucrative market for the companies involved in its value chain. One of the primary advantages of transmucosal drug delivery is it allows drugs to dodge the body’s natural defense mechanism. Many drugs, when administered by other delivery routes, may become ineffective due to high gastric acidity or first pass metabolism. As mucosal cavity, such as, nasal, vaginal, urethral, etc. has a permeable membrane that has a rich supply of blood vessels in the lining, drugs administered through these routes can be directly absorbed into the circulatory system and delivered at the target sites. Rise in trend of home health care is anticipated to drive the growth of the global transmucosal drug delivery market during the forecast period. Moreover, rapidly rising incidence of chronic disorders, including gastrointestinal, respiratory, and autoimmune disorders is anticipated to propel the global transmucosal drug delivery market in the near future. 

The global transmucosal drug delivery market can be classified on the basis of indication, route of administration, and region. On the basis of indication, the market can be divided into pain management, addiction treatment, hormonal therapies, and others. Based on route of administration, the market can be segmented into buccal, nasal, vaginal, and urethral. In terms of region, the global transmucosal drug delivery market can be categorized into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America dominates the global transmucosal drug delivery market, followed by Europe, owing to high adoption of advanced treatment approaches and high prevalence of various chronic and acute disorders in the region. Furthermore, the region is home to several key players which boosts the transmucosal drug deliver market in the region. Favorable reimbursement landscape, aggressive awareness programs, better diagnostic measures, and presence of advanced therapy brands make North America a highly promising market for transmucosal drug delivery. Major pharmaceutical companies in Europe, such as, Roche and Novartis have a diverse and multicultural skill-based research scientists and experienced managers adept at recognizing the market value of new methods. This has led to the adoption of superior practices in drug safety and development of new therapies in the region. In Asia Pacific, the transmucosal drug delivery market is expected to grow at a significant rate due to the rapidly growing health care industry in major countries, such as, China, India, Japan, and Australia. Changing lifestyles and increasing urbanization in these countries have led to a gradual escalation in incidence of lifestyle diseases, such as, cancer, diabetes, and heart conditions. This has created multiple opportunities for the bio-pharmaceutical sector to expand, conduct research, and allocate substantial budget for the same. Moreover, the rapidly expanding pharmaceutical industry has attracted the focus of public and private organizations toward this market. Development of health care infrastructure, rise in population, boom in the biotechnology industry, and increase in the burden of diseases necessitating diagnostics are driving the growth of the transmucosal drug delivery market in Latin America. In addition, better distribution network and its proximity to the U.S. geographically are boosting the growth of the transmucosal drug delivery market in Latin America. 

Major players operating in the global transmucosal drug delivery market include Cephalon, Inc., 3M Company, Antares Pharma, Inc., Teva Pharmaceuticals, West Therapeutic Development, LLC, Mylan, Inc., and BioDelivery Sciences International, Inc.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

The study is a source of reliable data on:

  • Market segments and sub-segments
  • Market trends and dynamics
  • Supply and demand
  • Market size
  • Current trends/opportunities/challenges
  • Competitive landscape
  • Technological breakthroughs
  • Value chain and stakeholder analysis

The regional analysis covers:

  • North America (U.S. and Canada)
  • Latin America (Mexico, Brazil, Peru, Chile, and others)
  • Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
  • Eastern Europe (Poland and Russia)
  • Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
  • Middle East and Africa (GCC, Southern Africa, and North Africa)

The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.

A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.

Highlights of the report:

  • A complete backdrop analysis, which includes an assessment of the parent market
  • Important changes in market dynamics
  • Market segmentation up to the second or third level
  • Historical, current, and projected size of the market from the standpoint of both value and volume
  • Reporting and evaluation of recent industry developments
  • Market shares and strategies of key players
  • Emerging niche segments and regional markets
  • An objective assessment of the trajectory of the market
  • Recommendations to companies for strengthening their foothold in the market   

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.


Transmucosal Drug Delivery Market

Pre Book